10-K Filing

Aqua Metals, Inc. CIK: 1621832 FY 2023

Filing Information

Form Type	10-K
Accession Number	`0001437749-24-009870`
Period End Date	20231231
Filing Date	20240328
Fiscal Year	2023
Fiscal Period	FY
XBRL Instance	aqms20231231_10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 71 Income Statement 32 Cash Flow Statement 83 Stockholders Equity 21

Balance Sheet 71 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$16.52M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.08M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	79.48M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	108.31M	shares	Point-in-time
Note receivable - LINICO	`NotesAndLoansReceivableNetCurrent`	$600.00K	USD	Point-in-time
Note receivable - LINICO	`NotesAndLoansReceivableNetCurrent`	-	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	107.88M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$12.00K	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	79.48M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$67.00K	USD	Point-in-time
Lease receivable	`SalesTypeLeaseNetInvestmentInLeaseExcludingAccruedInterestAfterAllowanceForCreditLossCurrent`	$15.53M	USD	Point-in-time
Treasury Stock, Common, Shares (in shares)	`TreasuryStockCommonShares`	428,566.00	shares	Point-in-time
Lease receivable	`SalesTypeLeaseNetInvestmentInLeaseExcludingAccruedInterestAfterAllowanceForCreditLossCurrent`	-	USD	Point-in-time
Treasury Stock, Common, Shares (in shares)	`TreasuryStockCommonShares`	0.00	shares	Point-in-time
Inventory	`InventoryNet`	$929.00K	USD	Point-in-time
Inventory	`InventoryNet`	$278.00K	USD	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	$47.00K	USD	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	-	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$263.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$181.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$23.21M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$18.30M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$10.35M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$7.34M	USD	Point-in-time
Intellectual property, net	`FiniteLivedIntangibleAssetsNet`	$461.00K	USD	Point-in-time
Intellectual property, net	`FiniteLivedIntangibleAssetsNet`	$281.00K	USD	Point-in-time
Investment in LINICO	`LongTermInvestments`	$2.00M	USD	Point-in-time
Investment in LINICO	`LongTermInvestments`	-	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.67M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$489.00K	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$15.30M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$10.29M	USD	Point-in-time
Total assets	`Assets`	$33.50M	USD	Point-in-time
Total assets	`Assets`	$33.60M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.07M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.84M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$1.78M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$2.47M	USD	Point-in-time
Building purchase deposit	`BuildingPurchaseDepositCurrent`	-	USD	Point-in-time
Building purchase deposit	`BuildingPurchaseDepositCurrent`	$3.25M	USD	Point-in-time
Lease liability, current portion	`OperatingAndFinanceLeaseLiabilityCurrent`	$275.00K	USD	Point-in-time
Lease liability, current portion	`OperatingAndFinanceLeaseLiabilityCurrent`	$307.00K	USD	Point-in-time
Note payable, current portion	`NotesPayableCurrent`	$5.90M	USD	Point-in-time
Note payable, current portion	`NotesPayableCurrent`	$35.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.31M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.61M	USD	Point-in-time
Lease liability, non-current portion	`OperatingAndFinanceLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Lease liability, non-current portion	`OperatingAndFinanceLeaseLiabilityNoncurrent`	$275.00K	USD	Point-in-time
Note payable, non-current portion	`BuildingPurchaseDepositNoncurrent`	$2.92M	USD	Point-in-time
Note payable, non-current portion	`BuildingPurchaseDepositNoncurrent`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$7.54M	USD	Point-in-time
Total liabilities	`Liabilities`	$12.59M	USD	Point-in-time
Commitments and contingencies (see Note 15)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (see Note 15)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock; $0.001 par value; 200,000,000 shares authorized; 108,308,661 and 107,880,095, shares issued and outstanding as of December 31, 2023, respectively and 79,481,751 shares issued and outstanding as of December 31, 2022	`CommonStockValue`	$79.00K	USD	Point-in-time
Common stock; $0.001 par value; 200,000,000 shares authorized; 108,308,661 and 107,880,095, shares issued and outstanding as of December 31, 2023, respectively and 79,481,751 shares issued and outstanding as of December 31, 2022	`CommonStockValue`	$108.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$220.11M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$249.69M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-223.22M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-199.28M	USD	Point-in-time
Treasury stock, at cost; common shares: 428,566 and nil as of December 31, 2023 and December 31, 2022, respectively	`TreasuryStockCommonValue`	-	USD	Point-in-time
Treasury stock, at cost; common shares: 428,566 and nil as of December 31, 2023 and December 31, 2022, respectively	`TreasuryStockCommonValue`	$516.00K	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$27.53M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$26.06M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$20.92M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$33.50M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$33.60M	USD	Point-in-time

Income Statement 32 line items

Line Item	Tag	Value	Unit	Period
Product sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$4.00K	USD	Annual
Product sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$25.00K	USD	Annual
Plant operations	`CostOfGoodsAndServicesSold`	$3.96M	USD	Annual
Plant operations	`CostOfGoodsAndServicesSold`	$6.28M	USD	Annual
Research and development cost	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$1.74M	USD	Annual
Research and development cost	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$1.81M	USD	Annual
Impairment of equipment	`ImpairmentOfLongLivedAssetsHeldForUse`	$579.00K	USD	Annual
Impairment of equipment	`ImpairmentOfLongLivedAssetsHeldForUse`	$4.85M	USD	Annual
Gain on disposal of property, plant and equipment	`GainLossOnSaleOfPropertyPlantAndEquipmentExcludingAmountInCostOfGoodSold`	$23.00K	USD	Annual
Gain on disposal of property, plant and equipment	`GainLossOnSaleOfPropertyPlantAndEquipmentExcludingAmountInCostOfGoodSold`	$596.00K	USD	Annual
General and administrative expense	`GeneralAndAdministrativeExpense`	$11.64M	USD	Annual
General and administrative expense	`GeneralAndAdministrativeExpense`	$9.81M	USD	Annual
Total operating expense	`CostsAndExpenses`	$15.57M	USD	Annual
Total operating expense	`CostsAndExpenses`	$24.49M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-15.57M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-24.46M	USD	Annual
Interest expense	`InterestExpense`	$621.00K	USD	Annual
Interest expense	`InterestExpense`	$125.00K	USD	Annual
Interest and other income	`InterestAndOtherIncome`	$1.15M	USD	Annual
Interest and other income	`InterestAndOtherIncome`	$262.00K	USD	Annual
Total other income (expense), net	`NonoperatingIncomeExpense`	$526.00K	USD	Annual
Total other income (expense), net	`NonoperatingIncomeExpense`	$137.00K	USD	Annual
Loss before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-23.94M	USD	Annual
Loss before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-15.43M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$2.00K	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$2.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-23.94M	USD	Annual
Net loss	`NetIncomeLoss`	$-15.43M	USD	Annual
Weighted average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	75.81M	shares	Annual
Weighted average shares outstanding, basic and diluted (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	93.93M	shares	Annual
Basic and diluted net loss per share (in dollars per share)	`EarningsPerShareBasic`	$-0.20	USD	Annual
Basic and diluted net loss per share (in dollars per share)	`EarningsPerShareBasic`	$-0.25	USD	Annual

Cash Flow Statement 83 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-23.94M	USD	Annual
Net loss	`NetIncomeLoss`	$-15.43M	USD	Annual
Depreciation and ROU asset amortization	`DepreciationAndRightOfUseAssetAmortization`	$882.00K	USD	Annual
Depreciation and ROU asset amortization	`DepreciationAndRightOfUseAssetAmortization`	$1.09M	USD	Annual
Amortization of intellectual property	`AmortizationOfIntangibleAssets`	$180.00K	USD	Annual
Amortization of intellectual property	`AmortizationOfIntangibleAssets`	$179.00K	USD	Annual
Warrant expense	`WarrantExpense`	-	USD	Annual
Warrant expense	`WarrantExpense`	$181.00K	USD	Annual
Fair value of common stock issued for consulting services	`FairValueOfCommonStockIssuedForConsultingServices`	$12.00K	USD	Annual
Fair value of common stock issued for consulting services	`FairValueOfCommonStockIssuedForConsultingServices`	$19.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$2.53M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$2.25M	USD	Annual
Fair value of common stock issued for director fees	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$21.00K	USD	Annual
Fair value of common stock issued for director fees	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$96.00K	USD	Annual
Amortization of deferred financing costs	`AmortizationOfFinancingCosts`	$13.00K	USD	Annual
Amortization of deferred financing costs	`AmortizationOfFinancingCosts`	$128.00K	USD	Annual
Gain on disposal of property, plant and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$23.00K	USD	Annual
Gain on disposal of property, plant and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$596.00K	USD	Annual
Impairment of equipment	`ImpairmentOfLongLivedAssetsHeldForUse`	$579.00K	USD	Annual
Impairment of equipment	`ImpairmentOfLongLivedAssetsHeldForUse`	$4.85M	USD	Annual
Impairment of LINICO investment	`EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount`	$1.40M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-120.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$55.00K	USD	Annual
Proceeds from sale and leasing of building	`ProceedsFromSalesTypeLeasePaymentsFinancingActivities`	$12.28M	USD	Annual
Proceeds from sale and leasing of building	`ProceedsFromSalesTypeLeasePaymentsFinancingActivities`	$920.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$651.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$155.00K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-82.00K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-93.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$22.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$139.00K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.43M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$209.00K	USD	Annual
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$307.00K	USD	Annual
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$497.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.15M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.19M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$5.60M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.77M	USD	Annual
Proceeds from sale of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$1.76M	USD	Annual
Proceeds from sale of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$70.00K	USD	Annual
Equipment deposits and other assets	`PaymentsToAcquireEquipmentDepositsAndOtherAssets`	$-91.00K	USD	Annual
Equipment deposits and other assets	`PaymentsToAcquireEquipmentDepositsAndOtherAssets`	$4.29M	USD	Annual
Investment in LINICO	`PaymentsToAcquireInvestments`	$500.00K	USD	Annual
Investment in LINICO	`PaymentsToAcquireInvestments`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.42M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-9.81M	USD	Annual
Proceeds from issuance of common stock, net of transaction costs	`ProceedsFromIssuanceOfCommonStockNet`	-	USD	Annual
Proceeds from issuance of common stock, net of transaction costs	`ProceedsFromIssuanceOfCommonStockNet`	$22.95M	USD	Annual
Proceeds from employee stock purchase plan	`ProceedsFromStockPlans`	$108.00K	USD	Annual
Proceeds from employee stock purchase plan	`ProceedsFromStockPlans`	$14.00K	USD	Annual
Payments on note payable	`RepaymentsOfNotesPayable`	-	USD	Annual
Payments on note payable	`RepaymentsOfNotesPayable`	$6.00M	USD	Annual
Proceeds from note payable, net	`ProceedsFromNotesPayable`	$2.93M	USD	Annual
Proceeds from note payable, net	`ProceedsFromNotesPayable`	$5.89M	USD	Annual
Cash paid for tax withholdings on RSUs vesting	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	Annual
Cash paid for tax withholdings on RSUs vesting	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$1.09M	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$140.00K	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Proceeds from ATM, net	`ProceedsFromIssuanceOfCommonStock`	$6.52M	USD	Annual
Proceeds from ATM, net	`ProceedsFromIssuanceOfCommonStock`	$3.79M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$12.51M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$22.45M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.05M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$9.44M	USD	Annual
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$7.08M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$16.52M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$8.14M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$7.08M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$16.52M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$8.14M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$84.00K	USD	Annual
Cash paid for interest	`InterestPaidNet`	$480.00K	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	$2.00K	USD	Annual
Acquisitions of property, plant and equipment included in accounts payable	`ChangeInPropertyAndEquipmentResultingFromChangeInAccountsPayable`	$451.00K	USD	Annual
Acquisitions of property, plant and equipment included in accounts payable	`ChangeInPropertyAndEquipmentResultingFromChangeInAccountsPayable`	$1.07M	USD	Annual
Acquisitions of property, plant and equipment included in accrued expenses	`ChangeInPropertyAndEquipmentResultingFromChangeInAccruedExpenses`	$1.86M	USD	Annual
Acquisitions of property, plant and equipment included in accrued expenses	`ChangeInPropertyAndEquipmentResultingFromChangeInAccruedExpenses`	$770.00K	USD	Annual
Increase in note receivable resulting from sale of investment	`ChangeInInvestingActivityResultingFromSaleOfInvestment`	$600.00K	USD	Annual
Increase in note receivable resulting from sale of investment	`ChangeInInvestingActivityResultingFromSaleOfInvestment`	-	USD	Annual
Increase in equity included in accrued expenses	`ChangeInInvestingActivityResultingFromIssuanceOfEquity`	$608.00K	USD	Annual
Increase in equity included in accrued expenses	`ChangeInInvestingActivityResultingFromIssuanceOfEquity`	-	USD	Annual

Stockholders Equity 21 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$27.53M	USD	Point-in-time
Balance	`StockholdersEquity`	$26.06M	USD	Point-in-time
Balance	`StockholdersEquity`	$20.92M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$2.25M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$2.53M	USD	Annual
Common stock issued upon RSU vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$2.00K	USD	Annual
Common stock issued upon RSU vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$-1.09M	USD	Annual
Common stock issued for consulting services	`StockIssuedDuringPeriodValueIssuedForServices`	$19.00K	USD	Annual
Common stock issued for consulting services	`StockIssuedDuringPeriodValueIssuedForServices`	$12.00K	USD	Annual
Common stock, Issued	`StockIssuedDuringPeriodValueNewIssues`	$21.00K	USD	Annual
Common stock, Issued	`StockIssuedDuringPeriodValueNewIssues`	$96.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-23.94M	USD	Annual
Net loss	`NetIncomeLoss`	$-15.43M	USD	Annual
Warrant expense related to Yulho agreement	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$181.00K	USD	Annual
Common stock issued for employee stock purchase plan sales (in shares)	`StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans`	192,707.00	shares	Annual
Common stock issued for employee stock purchase plan sales	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$122.00K	USD	Annual
Common stock issued for class action settlement (in shares)	`StockIssuedDuringPeriodSharesIssuedForClassActionSettlement`	469,366.00	shares	Annual
Common stock issued for class action settlement	`StockIssuedDuringPeriodValueIssuedForClassActionSettlement`	$501.00K	USD	Annual
Balance	`StockholdersEquity`	$27.53M	USD	Point-in-time
Balance	`StockholdersEquity`	$26.06M	USD	Point-in-time
Balance	`StockholdersEquity`	$20.92M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.